JP2001504461A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504461A5
JP2001504461A5 JP1998522063A JP52206398A JP2001504461A5 JP 2001504461 A5 JP2001504461 A5 JP 2001504461A5 JP 1998522063 A JP1998522063 A JP 1998522063A JP 52206398 A JP52206398 A JP 52206398A JP 2001504461 A5 JP2001504461 A5 JP 2001504461A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998522063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504461A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1997/000524 external-priority patent/WO1998020872A1/en
Publication of JP2001504461A publication Critical patent/JP2001504461A/ja
Publication of JP2001504461A5 publication Critical patent/JP2001504461A5/ja
Ceased legal-status Critical Current

Links

JP52206398A 1996-11-14 1997-11-14 治療有効成分として脂肪酸類もしくは脂肪族アルコール類またはそれらのモノグリセライド誘導体を含有する粘膜感染症治療用局所製剤 Ceased JP2001504461A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS4386 1996-11-14
IS4386 1996-11-14
PCT/DK1997/000524 WO1998020872A1 (en) 1996-11-14 1997-11-14 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections

Publications (2)

Publication Number Publication Date
JP2001504461A JP2001504461A (ja) 2001-04-03
JP2001504461A5 true JP2001504461A5 (enExample) 2005-07-14

Family

ID=36699955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52206398A Ceased JP2001504461A (ja) 1996-11-14 1997-11-14 治療有効成分として脂肪酸類もしくは脂肪族アルコール類またはそれらのモノグリセライド誘導体を含有する粘膜感染症治療用局所製剤

Country Status (10)

Country Link
US (1) US6596763B1 (enExample)
EP (1) EP0941087B1 (enExample)
JP (1) JP2001504461A (enExample)
AP (1) AP1209A (enExample)
AT (1) ATE442844T1 (enExample)
AU (1) AU729546B2 (enExample)
CA (1) CA2271843A1 (enExample)
DE (1) DE69739583D1 (enExample)
IS (1) IS5051A (enExample)
WO (1) WO1998020872A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648545B4 (de) † 1996-11-25 2009-05-07 Ceramtec Ag Monolithischer Vielschichtaktor mit Außenelektroden
ES2202872T3 (es) 1997-06-20 2004-04-01 Prometics Bodycare Limited Composicion protectora de la piel.
US6096332A (en) * 1998-06-30 2000-08-01 Mcneil-Ppc, Inc. Adding pharmaceutically active compounds to substrates
RU2186563C2 (ru) * 2000-02-25 2002-08-10 Государственное унитарное предприятие Тихоокеанский научно-исследовательский рыбохозяйственный центр Средство для лечения ожоговой раны
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
AU2002221412B2 (en) * 2000-12-05 2006-04-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
DE10156794B4 (de) * 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
EP2055300B1 (de) 2001-11-19 2016-01-27 Medigene AG Arzneimittel enthaltend Isopropylmyristat und ein Catechin
US20050032896A1 (en) * 2002-06-21 2005-02-10 Liisa Neumann Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism
US20050095281A1 (en) * 2003-03-14 2005-05-05 Optime Therapeutics, Inc. Liposomal formulations and methods of use
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
GB0317999D0 (en) * 2003-07-31 2003-09-03 Univ Liege Improvements in or relating to drug delivery systems
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
KR101232924B1 (ko) * 2003-09-09 2013-02-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 농축된 항균 조성물 및 방법
WO2005037300A1 (en) * 2003-10-09 2005-04-28 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
US20070276049A1 (en) * 2003-11-11 2007-11-29 Schlievert Patrick M Regulation of Cell Membrane-Mediated Effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
CA2578404A1 (en) * 2004-08-23 2006-03-02 Auckland Uniservices Limited Gastric therapies and compositions therefor
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
ES2411054T3 (es) * 2004-12-17 2013-07-04 Halldor Thormar Emulsiones antibacterianas concentradas estables de monocaprina en agua
TW200719884A (en) 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
CA2598985A1 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial pet wipes and methods
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
MX2007010908A (es) 2005-03-10 2007-12-05 3M Innovative Properties Co Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos.
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
DK2060192T3 (en) * 2007-10-17 2016-02-22 Wild Gmbh & Co Kg Rudolf Composition comprising lemon balm extracts
JP2009155257A (ja) * 2007-12-26 2009-07-16 Taiyo Corp 抗菌剤及びそれを含有する口腔用組成物並びに飲食品
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
DE102009008094A1 (de) 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
RU2516279C2 (ru) 2009-08-06 2014-05-20 Анитокс Корпорейшн Консервант для воды и корма
JP5864429B2 (ja) 2009-11-09 2016-02-17 スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc 架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
PH12013500117B1 (en) 2010-08-27 2019-07-17 Anitox Corp Antimicrobial formulation
WO2012035751A1 (ja) * 2010-09-14 2012-03-22 日油株式会社 除菌洗浄剤組成物
JP5749915B2 (ja) * 2010-11-02 2015-07-15 花王株式会社 オートインデューサー−2阻害剤
US20130261146A1 (en) * 2010-12-09 2013-10-03 The Research Foundation Of State University Of New York Nitric oxide and its biomedical significance
CA2832490C (en) 2011-04-13 2016-06-21 Biosafe Technologies, Inc. Compositions for internal and external insecticides, ovicides, repellents and wound healing
CA2848777A1 (en) 2011-10-20 2013-04-25 Anitox Corporation Antimicrobial formulations with pelargonic acid
JP2015504312A (ja) 2011-11-30 2015-02-12 アニトックス コーポレーション アルデヒド、有機酸及び有機酸エステルの抗微生物混合物
WO2017221276A1 (en) * 2016-06-20 2017-12-28 Capretto Ehf. Synergistic effects, augmenting antimicrobial effects of lipids
US20200069630A1 (en) * 2016-07-11 2020-03-05 Hennipen Life Sciences, Llc Compositions for sexually transmitted diseases
JP6754030B2 (ja) * 2017-04-20 2020-09-09 マイクロアルジェコーポレーション株式会社 モノアシルグリセロール、抗菌剤、及びモノアシルグリセロールの製造方法
US11246872B2 (en) 2019-06-14 2022-02-15 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof
US11572342B2 (en) 2020-09-18 2023-02-07 Niche Biopharmaceuticals LLC Antimicrobial and antiviral sulfur containing glycerol monoester derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US4520132A (en) * 1982-09-27 1985-05-28 Pennwalt Corporation Use of undecylenic acid to treat herpes labialis
AU566647B2 (en) * 1982-09-30 1987-10-29 Union Carbide Corporation Curable epoxy resin molding composition
US5208257A (en) 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5434182A (en) * 1987-12-31 1995-07-18 Isaacs; Charles E. Antibacterial fatty acid compositions
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
IL110380A0 (en) 1994-07-20 1994-10-21 Agis Ind 1983 Ltd Antiviral topical pharmaceutical compositions
DK1001759T3 (da) 1996-09-17 2005-10-10 Avanir Pharmaceuticals Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider

Similar Documents

Publication Publication Date Title
JP2000507844A5 (enExample)
JP2000505609A5 (enExample)
JP2000507565A5 (enExample)
JP2001507965A5 (enExample)
JP2000506916A5 (enExample)
JP2001505691A5 (enExample)
JP2000510894A5 (enExample)
JP2000503163A5 (enExample)
JP2000513715A5 (enExample)
JP2000513159A5 (enExample)
JP2000511016A5 (enExample)
JP2000515987A5 (enExample)
JP2000513709A5 (enExample)
JP2000507908A5 (enExample)
JP2000506333A5 (enExample)
JP2000512134A5 (enExample)
JP2001506118A5 (enExample)
JP2000512342A5 (enExample)
JP2002513273A5 (enExample)
JP2000508681A5 (enExample)
JP2000510509A5 (enExample)
JP2000510182A5 (enExample)
JP2000512651A5 (enExample)
JP2000507725A5 (enExample)
JP2001505207A5 (enExample)